Lobbying Relationship

Client

VHG Labs, Inc.

More records

Lobbying firm

GREENBERG TRAURIG, LLP

More records

  • Administrative and legislative monitoring and outreach on issues related to pharmaceutical reference standards.

Duration: to

General Issues: Pharmacy

Spending: about $100,000 (But it's complicated. Here's why.)

Agencies lobbied since 2018: U.S. Senate, Food & Drug Administration (FDA)

Affiliated organizations: LGC (Holdings) Limited

Related Foreign Entities: LGC (Holdings) Limited (Teddington, TW11 0LY, GBR); contribution to lobbying: $0; ownership 100%; LGC Investments Limited (100% LGC Holdings Limited) (Teddington, TW11 0LU, GBR); contribution to lobbying: $0; ownership 100%; LGC Group Holdings Limited (100% LGC Investments Limited) (Teddington, TW11 OLY, GBR); contribution to lobbying: $0; ownership 100%; LGC Science Investments Limited (100% LGC Group Holdings Limited) (Teddington, GBR); contribution to lobbying: $0; ownership 100%; LGC Science Holdings Limited (100% of LGC Science Investments Limited) (Teddington, TW11 0LY, GBR); contribution to lobbying: $0; ownership 100%; Teddington 2 Limited (100% LGC Science Holdings Limited) (Teddington, TW11 OLY, GBR); contribution to lobbying: $0; ownership 100%; LGC Science Group Limited (100% Teddington 2 Limited) (Teddington, TW11 0LY, GBR); contribution to lobbying: $0; ownership 100%; LGC Science Group Holdings Limited (100% LGC Science Group Limited) (Teddington, TW11 0LY, GBR); contribution to lobbying: $0; ownership 100%; Elwy 3 Limited (100% LGC Science Group Holdings Limited) (Teddington, TW11 0LY, GBR); contribution to lobbying: $0; ownership 100%; Elwy 2 Limited (100% Elwy 3 Limited) (Teddington, TW11 0LY, GBR); contribution to lobbying: $0; ownership 100%; Elwy 1 Limited (100% Elwy 2 Limited) (Ugland House, KY1-1104, CAY); contribution to lobbying: $0; ownership 100%; Figaro Capital & Co S.C.A. (100% Elwy 1 Limited) (L-2440, Luxembourg City, LUX); contribution to lobbying: $0; ownership 100%; Figaro Capital Limited (77.45% Figaro Capital & Co S.C.A.) (Ugland House, KY1-1104, CAY); contribution to lobbying: $0; ownership 77%; Figaro Aggregator L.P. (100% Figaro Capital Limited) (Ugland House, KY1-1104, CAY); contribution to lobbying: $0; ownership 77%; KKR Blue Co-Invest L.P. (51.53% Figaro Aggregator L.P.) (Ugland House, KY1-1104, CAY); contribution to lobbying: $0; ownership 39%; KKR European Fund IV, L.P. (27.59% Figaro Aggregator L.P.) (Ugland House, KY1-1104, CAY); contribution to lobbying: $0; ownership 21%

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Charles F. Bass U.S. Congressman (97 - 07) & (11 - 13)
Tim Hutchinson U.S. Senator (97-03); U.S. Congressman (93-97)
Randy Forbes U.S. Congressman (2001-2017)
Anna Laakmann n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page